| Primary |
| Drug Use For Unknown Indication |
32.4% |
| Blood Triglycerides Increased |
25.3% |
| Hypertriglyceridaemia |
8.9% |
| Blood Cholesterol Increased |
6.9% |
| Product Used For Unknown Indication |
5.6% |
| Hypertension |
3.9% |
| Prophylaxis |
3.2% |
| Myocardial Infarction |
2.2% |
| Blood Triglycerides |
1.5% |
| Hyperlipidaemia |
1.3% |
| Blood Cholesterol |
1.1% |
| Cardiac Disorder |
1.1% |
| Diabetes Mellitus |
1.1% |
| Gastritis |
1.1% |
| Back Pain |
0.9% |
| Diabetes Mellitus Non-insulin-dependent |
0.9% |
| Dyslipidaemia |
0.9% |
| Anaemia |
0.6% |
| Arterial Disorder |
0.6% |
| Depression |
0.6% |
|
| Medication Error |
14.1% |
| Off Label Use |
11.6% |
| Therapeutic Response Unexpected |
7.6% |
| Rash |
6.6% |
| Treatment Noncompliance |
6.6% |
| Blood Triglycerides Increased |
6.1% |
| Weight Increased |
5.1% |
| Wrong Drug Administered |
5.1% |
| Blood Glucose Increased |
4.0% |
| Chest Pain |
4.0% |
| Diarrhoea |
3.5% |
| Myalgia |
3.5% |
| Vomiting |
3.5% |
| Urticaria |
3.0% |
| Weight Decreased |
3.0% |
| Acute Myocardial Infarction |
2.5% |
| Condition Aggravated |
2.5% |
| Eructation |
2.5% |
| Flatulence |
2.5% |
| Low Density Lipoprotein Increased |
2.5% |
|
| Secondary |
| Product Used For Unknown Indication |
16.5% |
| Hypertension |
14.5% |
| Type 2 Diabetes Mellitus |
12.6% |
| Myocardial Infarction |
10.8% |
| Hyperlipidaemia |
5.5% |
| Hyperuricaemia |
5.1% |
| Hypercholesterolaemia |
4.6% |
| Hiv Infection |
4.4% |
| Hypertriglyceridaemia |
4.4% |
| Antiplatelet Therapy |
3.1% |
| Drug Use For Unknown Indication |
3.1% |
| Blood Triglycerides Increased |
2.9% |
| Ear Infection |
2.9% |
| Gastrooesophageal Reflux Disease |
1.8% |
| Gout |
1.5% |
| Gastric Ulcer |
1.3% |
| Hypertensive Cardiomyopathy |
1.3% |
| Renal Cell Carcinoma |
1.3% |
| Stent Placement |
1.3% |
| Diabetes Mellitus |
1.1% |
|
| Liver Injury |
20.5% |
| Thrombocytopenia |
13.3% |
| Liver Function Test Abnormal |
12.0% |
| Medication Error |
6.0% |
| Blood Alkaline Phosphatase Increased |
4.8% |
| Renal Failure Acute |
4.8% |
| Sexual Dysfunction |
4.8% |
| Petechiae |
3.6% |
| Syncope |
3.6% |
| Wrong Drug Administered |
3.6% |
| Acute Myocardial Infarction |
2.4% |
| Arteriovenous Fistula Occlusion |
2.4% |
| Arthralgia |
2.4% |
| Blood Cholesterol Increased |
2.4% |
| Haemothorax |
2.4% |
| Hyperglycaemia |
2.4% |
| Pancreatitis |
2.4% |
| Premature Baby |
2.4% |
| Vomiting |
2.4% |
| Angioedema |
1.2% |
|
| Concomitant |
| Drug Use For Unknown Indication |
27.4% |
| Product Used For Unknown Indication |
26.0% |
| Hypertension |
9.5% |
| Diabetes Mellitus |
3.8% |
| Hypercholesterolaemia |
3.3% |
| Pain |
3.1% |
| Type 2 Diabetes Mellitus |
2.7% |
| Muscle Spasms |
2.6% |
| Cardiac Disorder |
2.3% |
| Hiv Infection |
2.2% |
| Gastrooesophageal Reflux Disease |
2.1% |
| Myocardial Infarction |
2.1% |
| Atrial Fibrillation |
2.0% |
| Cardiac Failure |
1.7% |
| Prophylaxis |
1.7% |
| Obesity |
1.6% |
| Schizophrenia |
1.6% |
| Dyslipidaemia |
1.5% |
| Blood Cholesterol Increased |
1.5% |
| Depression |
1.4% |
|
| Weight Increased |
17.7% |
| Weight Decreased |
16.3% |
| Vomiting |
8.0% |
| Myocardial Infarction |
6.3% |
| Nausea |
4.3% |
| Pain |
4.3% |
| Pulmonary Embolism |
4.3% |
| Pain In Extremity |
4.0% |
| Hypertension |
3.7% |
| Ventricular Fibrillation |
3.7% |
| Myalgia |
3.3% |
| Neutropenia |
3.0% |
| Pancreatitis Acute |
3.0% |
| White Blood Cell Count Increased |
3.0% |
| Neuropathy Peripheral |
2.7% |
| Tendonitis |
2.7% |
| Urticaria |
2.7% |
| Myositis |
2.3% |
| Thrombocytopenia |
2.3% |
| Transient Ischaemic Attack |
2.3% |
|
| Interacting |
| Nephritis |
66.7% |
| Hypertriglyceridaemia |
33.3% |
|
| Immunosuppressant Drug Level Increased |
50.0% |
| Joint Swelling |
50.0% |
|
